SCHEMBL1094750

SCHEMBL1094750

CN1C2CCC1C(NC(=O)c1ccc(C(F)(F)F)cc1C1CC1)(c1ccccc1)CC2

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1096250 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL17081980 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL1096198 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL1095224 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL1096200 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL1096253 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL17081973 0.87 SLC6A9 (0.47) SLC6A9
SCHEMBL1094321 0.85 SLC6A9 (0.50) SLC6A9
SCHEMBL1095414 0.85 SLC6A9 (0.50) SLC6A9
SCHEMBL1094324 0.85 SLC6A9 (0.50) SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585456-B1 AMIDO-TROPANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2015-09-16 EP claimed
US-8153653-B2 Amido-tropane derivatives HOFFMANN-LA ROCHE INC. (US) 2012-04-10 US claimed
US-20110312993-A1 AMIDO-TROPANE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2011-12-22 US claimed
EP-2585456-B1 AMIDO-TROPANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2015-09-16 EP disclosed
EP-2585456-B1 AMIDO-TROPANE DERIVATIVES HOFFMANN LA ROCHE (CH) 2015-09-16 EP disclosed
US-8153653-B2 Amido-tropane derivatives HOFFMANN-LA ROCHE INC. (US) 2012-04-10 US disclosed
US-8153653-B2 Amido-tropane derivatives HOFFMANN-LA ROCHE INC. (US) 2012-04-10 US disclosed
US-8153653-B2 Amido-tropane derivatives HOFFMANN-LA ROCHE INC. (US) 2012-04-10 US disclosed
WO-2011161006-A1 AMIDO-TROPANE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-12-29 WO disclosed
US-20110312993-A1 AMIDO-TROPANE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed
US-20110312993-A1 AMIDO-TROPANE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed
US-20110312993-A1 AMIDO-TROPANE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2011-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312993-A1 AMIDO-TROPANE DERIVATIVES SLC1A2, SLC18A2, SLC6A1 SLC6A9 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.